Do sex differences in CEOAEs and 2D:4D ratios reflect androgen exposure? A study in women with complete androgen insensitivity syndrome. by van Hemmen, Judy et al.
RESEARCH Open Access
Do sex differences in CEOAEs and 2D:4D
ratios reflect androgen exposure? A study
in women with complete androgen
insensitivity syndrome
Judy van Hemmen1,2, Peggy T. Cohen-Kettenis2, Thomas D. Steensma2, Dick J. Veltman3 and Julie Bakker1,2,4*
Abstract
Background: Studies investigating the influence of perinatal hormone exposure on sexually differentiated traits
would greatly benefit from biomarkers of these early hormone actions. Click-evoked otoacoustic emissions show
sex differences that are thought to reflect differences in early androgen exposure. Women with complete androgen
insensitivity syndrome (CAIS), who lack androgen action in the presence of XY-chromosomes, enabled us to study
the effect of complete androgen inaction. The main goal was to investigate a possible link between click-evoked
otoacoustic emissions and effective androgen exposure and, thus, whether this can be used as a biomarker. In
addition, we aimed to replicate the only previous 2nd vs 4th digit-ratio study in women with CAIS, because despite
the widely expressed criticisms of the validity of this measure as a biomarker for prenatal androgen exposure, it still
is used for this purpose.
Methods: Click-evoked otoacoustic emissions and digit ratios from women with CAIS were compared to those
from control men and women.
Results: The typical sex differences in click-evoked otoacoustic emissions and digit ratios were replicated in the
control groups. Women with CAIS showed a tendency towards feminine, i.e., larger, click-evoked otoacoustic
emission amplitudes in the right ear, and a significant female-typical, i.e., larger, digit ratio in the right hand.
Although these results are consistent with androgen-dependent development of male-typical click-evoked
otoacoustic emission amplitude and 2nd to 4th digit ratios, the within-group variability of these two measures was
not reduced in women with CAIS compared with control women.
Conclusions: In line with previous studies, our findings in CAIS women suggest that additional, non-androgenic,
factors mediate male-typical sexual differentiation of digit ratios and click-evoked otoacoustic emissions. Consequently,
use of these measures in adults as retrospective markers of early androgen exposure is not recommended.
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Background
Prenatal androgen exposure plays an important role in
the development of sex differences in a variety of neural
and behavioral characteristics (e.g., reviewed in [1]). To
investigate potentially permanent, i.e., organizational, ef-
fects of prenatal androgen exposure in humans, a pro-
spective study design including direct measurements of
fetal testosterone levels, preferably at several gestational
time points, would be ideal. However, this type of study
design is expensive, time consuming and, above all, in-
curs fetal risks and thus is unethical. A desirable alterna-
tive would be to use retrospective measures to index
prenatal testosterone exposure and action in both sexes.
Otoacoustic emissions (OAEs; e.g., reviewed in [2])
might represent such an indirect marker because sex dif-
ferences which potentially reflect sex differences in early
androgen action have been demonstrated. OAEs are
sounds measurable in the external ear canal that origin-
ate from the cochlea as a by-product of the cochlear
amplification mechanism [3–5]. They can occur spon-
taneously (spontaneous OAEs; SOAEs) or in response to
acoustic stimuli such as clicks (click-evoked OAEs;
CEOAEs). Previous studies showed that women had
more and stronger SOAEs and larger CEOAE ampli-
tudes than men ([6, 7]; for review see [2]). These sex dif-
ferences were not only present in adults but also were
found in neonates and appeared to remain reasonably
constant throughout life [8–12].
A direct investigation of the proposed link between
prenatal hormone levels and OAEs later in life is compli-
cated in humans because hormonal manipulations are
unethical and the incorporation of direct fetal hormone
level measurements in a study design is challenging. To
date, OAEs have not been related to fetal testosterone
levels across development. Another approach used in
examining the validity of OAEs as a marker of early an-
drogen exposure is to study disorders/differences of sex
development (DSD) in which the development of
chromosomal, gonadal, and/or anatomical sex is atypical
[13]. In 46,XX women with congenital adrenal hyperpla-
sia (CAH), a condition characterized by excessive pre-
natal androgen production, the number of SOAEs was
lower (masculinized) compared to control women.
However, this was found in the right ear only, and no
differences were observed in the CEOAE amplitude of
either ear [14].
A DSD of particular interest when studying androgenic
effects is complete androgen insensitivity syndrome
(CAIS). Women with CAIS have a 46,XY karyotype, but
no effective androgen action due to non-functional andro-
gen receptors caused by genetic mutations in the andro-
gen receptor gene. This leads to a female phenotype
despite testosterone levels, produced by their abdominal
testes, that are within or above the male range [15, 16].
Women with CAIS thus provide a unique opportunity to
study whether the reported sex differences in OAEs are
likely to originate from differences in androgen action or
other factors that might influence sexual differentiation,
such as sex chromosome configuration.
To date, the single OAE study that has been per-
formed in women with CAIS found no differences be-
tween control subjects and women with CAIS. Both the
number of SOAEs and amplitude of CEOAEs were
equivalent in CAIS and control women [14]. It should
be noted that in this study, the typical sex difference in
CEOAE amplitude was not replicated in the control
groups and the sample sizes were very small, also for the
control groups (7 women with CAIS, 13 control women,
10/11 control men). Also, groups were not matched for
age and ethnic background. Therefore, no firm conclu-
sions can be drawn from this study about sex differences
in CEOAEs and whether any differences observed can
be attributed to differential androgen action. Because
strong evidence for a link between early androgen ex-
posure and CEOAEs is still lacking, the primary object-
ive of the present study was to investigate the proposed
association between androgens and CEOAE amplitude
by comparing women with CAIS to control men and
women.
The 2nd digit to 4th digit (2D:4D) ratio, which is the
length of the 2nd digit (index finger) relative to that of
the 4th digit (ring finger), is another measure that has
been proposed to reflect sex differences in prenatal an-
drogen exposure. The 2D:4D ratio is generally larger in
women than in men ([17]; for meta-analysis, see [18]).
However, the validity of this measure as a marker of pre-
natal androgen exposure has been criticized. Two digit-
ratio studies [19, 20] attempted to measure fetal andro-
gen levels through amniocentesis, and their results were
inconclusive. The 2D:4D ratio showed a negative correl-
ation with testosterone content measured in amniotic
fluid in newborn girls, but not in boys [19]. Also, at age
2 years, a negative correlation was observed between
2D:4D ratio and the ratio of testosterone to estradiol
(T:E) measured in amniotic fluid [20]. However, it
should be noted that the T:E ratio in the latter study [20]
was based on a sample of 29 children, boys and girls
combined, and given the small sample and sex differ-
ences in all three variables measured (testosterone, estra-
diol, 2D:4D) likely was spurious. In addition, a recent
meta-analysis found no associations between functional
androgen receptor (AR) gene variants (CAG and GGC
repeat-length polymorphisms) and 2D:4D ratio [21], pro-
viding evidence against major AR gene-related effects
(for a discussion of additional evidence and arguments
against AR gene-related effects on 2D:4D, see [21]).
Digit-ratio studies in DSDs suggested a lower, i.e.,
more “masculine,” digit ratio in women with CAH than
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in control women for either the right hand [22, 23] or
for both hands [24, 25], although a “feminine” digit ratio
in CAH was reported in yet another study [26]. Individ-
uals with Klinefelter syndrome, who have 1 Y- and 2 or
more X-chromosomes and might have reduced fetal an-
drogen exposure, showed a higher, i.e., “feminized”, digit
ratio than control men [27]. A study in 16 women with
CAIS showed that their digit ratios were feminized,
which, along with the majority of findings in DSDs,
points to a link between fetal androgen exposure and
the 2D:4D ratio [28]. However, some important caveats
have been discussed by the authors of this study [28]
and in a commentary on this paper [29]. First, the effect
size of the difference between women with CAIS and
control men was only moderate, and second, the vari-
ability in digit ratios was not smaller in women with
CAIS than in either the male or female control subjects.
If fetal androgen exposure alone determines 2D:4D ra-
tios, then, one would expect less variability in women
with CAIS because they are completely insensitive to
any androgen actions. This has led to the conclusion
that 2D:4D digit ratio is partially determined by fetal an-
drogen exposure but that the relationship is too small to
use digit ratio as a reliable marker for fetal androgen ex-
posure in individual subjects (as cited in [28]). Regard-
less of this conclusion and other important critical
arguments against AR-gene-related effects (summarized
by [21]), numerous investigators continue to use the
digit ratio as an index of fetal androgen action. The
study by Berenbaum et al. [28] included a sample of only
16 women with CAIS, which is a reasonable sample con-
sidering the rareness of the syndrome. However, the stat-
istical power of the comparisons made with control
subjects was quite low. For this reason, we sought to
replicate this study using a larger sample of CAIS
women as well as control men and women. Thus, this is




Subjects whose data were used in the present study were
Caucasian, did not report having a male twin, and had a
heterosexual orientation. A heterosexual orientation was
defined as an androphilic orientation, i.e., attraction to
men, in control women and women with CAIS, and a
gynephilic orientation, i.e., attraction to women, in con-
trol men (sexual orientation score >5 on the Dutch ver-
sion of the Klein Sexual Orientation Grid ([30]; adapted
from [31])). Note that we used Caucasian as selection
criterion, because all women with CAIS were Caucasian,
and ethnicity affects CEOAEs and 2D:4D digit ratios.
Not all subjects met all our additional inclusion criteria
for both the CEOAE and digit ratio analyses. Therefore,
further details of the participant groups will be described
for both analyses separately.
For the CEOAE analyses, subjects were divided into
four groups: women with CAIS, control men, and, be-
cause hormonal contraceptives might influence the
CEOAE amplitude [32, 33], two groups of control
women, those using oral contraceptives (OC-women)
and normally cycling (NC-)women not using any hor-
monal contraceptives. To minimize effects related to
handedness [7], all subjects had a right-hand preference
for writing and handedness scores of ≥+7 on the Dutch
Handedness Inventory ([34]; range −10 = extreme left-
handed, +10 = extreme right-handed). All control
women were pre-menopausal and not pregnant. NC-
women were not tested during the first days of the fol-
licular phase (menses), when sex hormone levels are
low, but otherwise could be tested any time during the
remainder of their cycle. OC-women also were tested
only once and only on a day when they were taking
doses of OC, i.e., not during the first week of the cycle
when OC is not taken. All OC-women used a monopha-
sic OC, containing ethinylestradiol and levonorgestrel
(20/100 μg (N = 2), 30/150 μg (N left ear = 27, N right
ear = 30) or 50/125 μg (N = 2)). The data for both ears
were excluded for all subjects exposed to high levels of
noise in the 24 h preceding the measurement and from
subjects who reported having a hormonal disorder or
taking hormonal medication that might influence sex
hormone levels (with the exception of oral contracep-
tives for OC-women and hormone replacement therapy
in women with CAIS). When severe ear problems were
reported or measurements were invalid (see “CEOAE” in
methods section), the data from that particular ear were
excluded from the analyses. These criteria resulted in a
total of 125 usable measurements of the left and 132 us-
able measurements of the right ear in all groups com-
bined, see Table 1 for Ns and age per group.
For the digit-ratio analyses, the use of OCs was not
a factor of interest; therefore, the data of only three
groups were used for this part of the study, women
with CAIS, control men, and NC-women. The latter
group will be referred to as “control women.” It is
important to mention that controls were completely
unrelated to the women with CAIS. The 2D:4D ratios
of 7 left and 13 right hands were excluded from the
analyses because of reported digit or hand trauma
with a possible influence on digit length, or due to
technical problems with the scan of the hand. To in-
crease the size of the control groups, data from 88
control men and 109 control women from a previous
digit ratio study, all heterosexual and 18 years and
older, were added to the data acquired for the current
study (see [35] for further details). This resulted in a
total of 306 usable left and 300 usable right-hand
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2D:4D ratios for all groups combined (see Table 1 for
Ns and age per group and per hand).
All women with CAIS had gender identity scores in
ranges comparable to reference groups of healthy
women, which was assessed with a Gender Questionnaire
(Callens et al. submitted; adapted from [36]) with six
questions added to the original questionnaire to cover
the criteria for a gender identity disorder based on the
Diagnostic and Statistical Manual of Mental Disorders
[37]. The diagnosis of CAIS was based on clinical charac-
teristics in all 22 women with CAIS included in the ana-
lyses. Furthermore, in contrast to the Berenbaum et al.
study ([28], a mutation analysis of the androgen receptor
(AR) gene using genomic DNA was performed. In 14
participants, the clinical diagnosis was confirmed with a
mutation in the AR-gene, in 7 participants, an unclassi-
fied variant of the AR-gene mutation was found, and in 1
participant, the result of the analysis was inconclusive.
All women with CAIS were gonadectomized and, with
one exception, took hormone replacement therapy
(HRT) to compensate for the lack of gonadal sex hor-
mone production. HRT consisted of orally, transdermally,
or subcutaneously administered estradiol (N = 15), a
combination of estradiol and dydrogesteron (N = 3),
conjugated estrogens (N = 2), or a monophasic oral
contraceptive containing ethinylestradiol and levonorges-
trel (N = 1).
Women with CAIS were recruited from the databases
of the VU University Medical Center Amsterdam and the
Erasmus University Medical Center-Sophia Children’s
Hospital Rotterdam, as well as from the support group
DSDNederland. The majority of these women with CAIS
were recruited for a larger neuroimaging study (e.g., de-
scribed in [38]). Control subjects were recruited from em-
ployees of the VU University Medical Center and by using
flyers and advertisements in a local newspaper.
CEOAEs
CEOAEs were recorded using the ILO288 Echoport
(Otodynamics Ltd., UK) connected to a laptop with EZ-
screen software. Prior to a testing session, the probe was
calibrated using a calibration cavity. For each participant,
a single-use probe tip was selected with an appropriate
size to best fit and seal the external ear canal. Partici-
pants were tested in a quiet room while seated and were
instructed not to move and particularly to avoid jaw ac-
tion, swallowing, and vocalizations to prevent cable-rub
and ear canal noise during CEOAE recording. CEOAEs
always were measured first for the right ear. The
QuickScreen (non-linear) mode was used with a 2.5 to
12.5-ms post-click response window. The click stimu-
lus level was set at 80 dB sound-pressure level (SPL)
(M = 80.23, SD = 0.80), and 250 responses with a noise
level below 6 mPa were recorded per ear. CEOAEs
Table 1 Sample characteristics, CEOAE amplitude, and 2D:4D ratio per group
CAIS Control women Control Men F/χ2 p η2
M/Mdn (SD/IQR) M/Mdn (SD/IQR) M/Mdn (SD/IQR)
CEOAE left
N 18 74 33
Agea 27.80 (18.11) 27.29 (13.19) 28.30 (19.11) 0.937 0.626
Amplitude (dB SPL) 10.96 (2.72) 12.85 (4.14) 9.42 (4.19) 8.789 <0.001 0.126
CEOAE right
N 18 77 37
Agea 27.80 (18.11) 27.66 (17.76) 28.30 (19.60) 0.341 0.843
Amplitude (dB SPL) 12.48 (2.94) 12.85(4.36) 10.23 (3.77) 5.357 0.006 0.077
2D:4D ratio left
N 21 156 129
Agea 27.65 (23.9) 27.00 (14.0) 26.82 (14.8) 0.655 0.721
Ratioa 0.965 (0.037) 0.980 (0.037) 0.963 (0.045) 13.565 0.001 0.044
2D:4D ratio right
N 20 154 126
Agea 27.80 (23.0) 27.00 (12.8) 26.91 (15.0) 1.720 0.423
Ratioa 0.978 (0.038) 0.976 (0.046) 0.956 (0.043) 22.819 0.000 0.076
Note: Statistics from parametric tests are expressed in M = mean, SD = standard deviation, F. Statistics from non-parametric tests are expressed in Mdn = median,
IQR = interquartile range (these are more appropriate statistics for non-parametric data), and χ2. Bold p values represent a significant (p < 0.05) main effect of
group. η2 = partial eta squared values for the three group comparisons.
aNon-parametric tests were used for statistical analysis of this variable
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were recorded in five frequency bands (1000, 1414,
2000, 2828, and 4000 Hz), but only the absolute
CEOAE response, which relates to the total OAE en-
ergy recorded across the frequency range, was used for
the analyses. A recording was considered valid when
showing a minimum amplitude of 1 dB SPL and a
whole band reproducibility of at least 70% based on
two independently recorded waveforms.
Digit ratios
For the present study, high-resolution (600 × 600 dpi)
digital scans of the hands were made using a Canon ima-
geRUNNER ADVANCE. The left and right hand were
scanned separately. Participants were asked to remove
rings and gently press their hand on the glass of the
scanning device while straightening and slightly spread-
ing their fingers. Prior to scanning, a photocopy of the
hand was made to ensure correct positioning of the
hand and quality of the photocopy. Two independent
raters, unaware of the participant’s group membership,
measured the digits using AutoMetric (version 2.2;
deBruine, 2006), a program designed to measure hand
properties from digital images. The raters manually
marked the fingertip and the middle of the basal crease
on the ventral surface of the 2nd and 4th digit. The soft-
ware used these landmarks to automatically calculate the
length of the 2nd and 4th digit in pixels and the 2D:4D
ratio for each hand. The intra-class correlation coeffi-
cient (two-way mixed effects model, type absolute
agreement) was >0.997 for all four (left and right 2nd
and 4th) digits vs 0.916 and 0.775 for the calculated digit
ratios of the left and right hand, respectively, indicating
a high interrater reliability. Therefore, the average of
each digit ratio from the two raters was calculated and
used for the analyses. See [35] for the methods used for
the additional control subjects.
Data analysis
Statistical analyses were performed with IBM SPSS
Statistics for Windows, Version 22 (IBM Corp., Armonk,
NY, USA). First, we used a t test to assess whether OC-
and NC-women showed differences in CEOAE. Because
no differences were found (see “Results” section), OC-
and NC-women were grouped for subsequent analyses
in order to have a larger sample size for the women con-
trol group. We used one-way analyses of variance
(ANOVA), followed by Bonferroni post hoc pairwise
comparisons, to analyze differences in left and right
CEOAE amplitudes between control men, control
women, and women with CAIS. Effect sizes for pairwise
comparisons of the CEOAE data are expressed in
Cohen’s d, with effect sizes of 0.2, 0.5, and 0.8 referring
to small, medium, and large differences, respectively
[39]. Cohen’s d was calculated as the mean difference
between the two groups divided by the pooled standard
deviation which is the square root of the weighted sum
of the individual variances for the two groups. Differ-
ences in variance between women with CAIS and the
control groups were assessed with pairwise Levene’s
tests.
Kruskal-Wallis and post hoc Mann-Whitney U tests
were used for the between-group analyses of the left and
right 2D:4D ratio, because the right-hand data of women
with CAIS and control men were not normally distrib-
uted. Effect sizes for pairwise comparisons of the 2D:4D
ratio data are expressed in d, as calculated from r (Z
statistic divided by the square root of the combined sam-
ple size of the two groups). Differences in variance be-
tween women with CAIS and the control groups were
assessed with pairwise Levene’s tests.
For all analyses, results were considered significant at
a p < 0.05 threshold. Post hoc pairwise test statistics were




The CEOAE amplitudes of NC-women (left ear M = 12.68,
SD = 4.08; right ear M = 12.93, SD = 3.67) and OC-
women (left ear M = 13.07, SD = 4.26; right ear M = 12.74,
SD = 5.16) showed no significant differences (p = 0.690
and 0.859 for left and right ear, respectively). Data from
both OC- and NC-women were grouped together to have
one large group of control women in the ANOVA to as-
sess between-group differences. This ANOVA showed a
significant effect of group on CEOAE amplitude in both
ears (Table 1). Figure 1a presents the mean left and right-
ear CEOAE amplitude for each group with error bars
representing the 95% confidence interval. Post hoc pair-
wise comparisons (Table 2) revealed the expected sex dif-
ferences between control men and control women [2] in
both ears, with greater mean CEOAEs in control women
and medium-to-large effect sizes. The greater mean right-
ear amplitude in women with CAIS than in control men
was however not significant (p = 0.163). The other post
hoc comparisons also did not reveal significant between-
group differences. Variances for both the left and right-ear
CEOAE amplitudes did not differ between women with
CAIS and the control groups (all ps > 0.05 even before ap-
plying a Bonferroni correction for multiple comparisons).
Digit ratios
For both the left and right-hand 2D:4D ratios, a main ef-
fect of group was found (Table 1). Median digit ratios
and the interquartile range (IQR) are displayed in Fig. 1b.
Post hoc comparisons showed the typical significant sex
difference in both hands [18], with higher 2D:4D ratios
in control women than men and medium effect sizes. In
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the right hand, women with CAIS also showed a higher
digit ratio than control men, with a small-to-medium ef-
fect size. No other comparisons reached significance.
Levene’s tests showed no differences in variance between
women with CAIS and control groups in digit ratios of
either hand (all ps > 0.05 even before applying a Bonfer-
roni correction for multiple comparisons).
Discussion
The main objective of the present study was to replicate
the previous CEOAE study [14] and the previous digit-
ratio study [28] in women with CAIS in order to further
assess the use of each of these variables as indirect indi-
cators of fetal testosterone action. The results from each
measure will be discussed separately.
CEOAEs
In line with previous studies, (e.g., reviewed in [2]), sex
differences with medium-to-large effect sizes were found
in both ears, with higher amplitudes in control women
than in men. Although none of the differences between
women with CAIS and the control groups reached
statistical significance, there was a trend towards a fe-
male-typical CEOAE amplitude in the right ear of
women with CAIS. A similar tendency for female-typical
CEOAEs in women with CAIS was, however, not found
in the left ear.
Although conclusions based on the right-ear tendency
towards female-typical CEOAEs in women with CAIS
should be drawn with great caution, the lack of a signifi-
cant difference between women with CAIS and control
men is likely the result of low statistical power caused by
the small sample of women with CAIS, along with the
strict statistical threshold that was applied (i.e., two-tailed
tests and corrections for multiple comparisons). Taking
this into consideration, the direction of the effect is in line
with the hypothesis that low prenatal androgen action is
associated with stronger, female-typical, CEOAEs.
Because the only previous OAE study in DSDs failed
to replicate the typical sex difference in CEOAEs [14],
an interpretation of those results and comparison with
the results from the present study is difficult. However, a
sex difference, with medium-to-large effect sizes, was
replicated in SOAEs, which in general show a large
Fig. 1 a Mean (+95% confidence interval) CEOAE amplitude in the left and right ear per group. b Median (+IQR) left and right-hand 2D:4D ratio
per group. CM control men, CW control women
Table 2 Post hoc tests, effect sizes, and differences in variance for CEOAE amplitude and 2D:4D ratios
Left Right
p Cohen’s d Levene’s p p Cohen’s d Levene’s p
CEOAE amplitude (dB SPL)
Control men vs control women <0.001 0.824 1.000 0.005 0.642 0.399
Control men vs CAIS 0.571 0.436 0.285 0.163 0.666 1.000
Control women vs CAIS 0.220 0.540 0.273 1.000 0.097 0.174
2D:4D ratioa
Control men vs control women 0.001 0.438 0.058 0.000 0.574 0.469
Control men vs CAIS 1.000 0.087 0.152 0.043 0.414 0.440
Control women vs CAIS 0.411 0.225 0.513 1.000 0.002 0.606
Note: Bold p values represent a significant (p < 0.05) between-group difference after applying a Bonferroni correction for multiple comparisons.
aNon-parametric tests were used for statistical analysis of this variable
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correlation with CEOAEs [40], suggesting an overlap in
mechanisms responsible for the production of these
auditory characteristics. Accordingly, females with CAH
showed a masculinized number of SOAEs in the right
ear [2]. Although the number of SOAEs in women with
CAIS was not significantly different from control men
or women, the effect sizes revealed a deviation from
control men (d = 0.56) in the direction of control women
in the left ear. This is in the same direction, although
with a slightly smaller effect size, as the female-typical
tendency found in right-ear CEOAEs in the present
study.
The authors of the previous OAE study in DSDs [14]
suggested that OAEs “may prove useful as bioassays for
assessing early brain exposure to androgens” (as cited in
[14]), although those authors did emphasize the need for
replication. This statement is only statistically supported
by the right-ear SOAE results of the CAH group in their
study, and it should be noted that a chance finding can-
not be ruled out when taking into account the small
sample sizes for DSD and control groups in the study by
Wisniewski et al. [14]. In the present study, we have fur-
ther assessed this potential association between CEOAEs
and fetal androgen exposure by examining the variability
of this measure in women with CAIS. If effective andro-
gen action, prenatally and/or later in life, were a main
determinant of observed sex differences in CEOAE amp-
litude, then women with CAIS would show a much
smaller variability in CEOAE amplitudes due to their
complete androgen inaction as opposed to the more
variable androgen exposure to be expected in control
men as well as women. However, in the current study,
the variability of CEOAE amplitude for both ears was
not reduced in women with CAIS. Therefore, although
the right-ear results point to a role for effective andro-
gen exposure in CEOAE amplitude and the left-ear re-
sults are inconclusive, the finding that CEOAEs in
women with CAIS were as variable as in both control
groups suggests that factors in addition to fetal androgen
exposure influence the CEOAE amplitude measured in
adulthood.
Previous studies have addressed the potential influence
of circulating hormone levels in adulthood on OAEs.
CEOAE amplitudes in control men correlated with sea-
sonal variation in testosterone levels [41]. However,
these effects cannot explain the variability of CEOAE
amplitudes in women with CAIS, as they are insensitive
to androgens throughout life. In addition, small changes
related to the menstrual cycle have been reported for
SOAEs [42–45], with some of these studies suggesting a
positive association with high estrogen phases of the
menstrual cycle. Estrogen receptors have been found in
the adult human cochlea [46], and thus, estrogens could
affect cochlear function. With one exception, all women
with CAIS included in our CEOAE analyses used HRT
containing estradiol. Therefore, the tendency towards
female-typical CEOAE amplitude in the right ear might
result from high estradiol levels in combination with the
absence of androgen effects. Estrogen actions also could
explain the variability in CEOAE amplitude in women
with CAIS, because they have normally functioning es-
tradiol receptors and variable estradiol levels from HRT.
Previous studies also have suggested that oral contra-
ceptives might have a defeminizing or masculinizing in-
fluence on CEOAEs [32, 33], although only the study by
Snihur and Hampson reported significant effects in sup-
port of this hypothesis. Because of this proposed influ-
ence, both OC- and NC-women were included in the
present study. However, because no CEOAE amplitude
differences were found between these groups, we
grouped both samples in one large female control group.
Although an investigation of OC-related effects in con-
trol women was not the primary aim of the present
study, we will briefly discuss this issue because our re-
sults differ from the study by Snihur and Hampson [32].
In the present study, the sample sizes were larger and
the OC formulation more homogeneous, with all women
using a monophasic OC, whereas in the study by Snihur
and Hampson only 40% used a monophasic OC and
60% used a triphasic OC with varying progesterone dos-
ages over the cycle. In addition, in the present study,
OC-women were tested at a day of OC use, whereas
Snihur and Hampson did not take this factor into ac-
count. Based on the typical 4-week OC cycle, in which
during 1 week no OC is used, in theory, a quarter of the
OC using women in the Snihur and Hampson study
could have been tested on a day without OC use, and
thus could have had much lower estrogen and progester-
one levels. Although purely speculative, such a bias
could explain the lower CEOAE amplitudes in OC-
women in their study. The finding that CEOAEs did not
differ between OC- and NC-women in the present study,
therefore, argues against the hypothesis proposed by
Snihur and Hampson [32], that ovarian-derived estrogen,
and not the synthetic ethinylestradiol used in OC formu-
lations, acts to facilitate the cochlear amplifiers. Instead,
it is at least possible that the differences found in the
previous study were the result of differences in estrogen
levels, regardless of their origin.
A limitation of the present study is that potential men-
strual cycle-related effects were not controlled for in
NC-women. Although in a subgroup of NC-women,
who were also included in a larger magnetic resonance
imaging study, attempts have been made to perform
testing only during the high estrogen phase of the men-
strual cycle (around ovulation), serum hormone levels
that were obtained in this subgroup revealed that these
women were tested throughout different phases of their
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cycle, although not during menses. In the additional sub-
jects that were tested to increase the sample size for the
current study, no blood samples were obtained. There-
fore, we tested this new group throughout the menstrual
cycle, with the exception of the menstrual phase, to
match the initial group of NC-women. In addition, test-
ing NC-women throughout their menstrual cycle (except
for the menstrual phase) reduced a potential cycle-
related bias, and this group would serve as a more typ-
ical control group for women with CAIS, because the
latter group used hormone replacement in different dos-
ages. Furthermore, exclusion of the menstrual phase
would be a better match to women with CAIS, who con-
tinuously use their HRT, and OC-women, who were not
tested during their week without OC intake.
Although in the present study the sample size of
women with CAIS is twice as large as in the study by
Wisniewski et al. [14], thereby increasing statistical
power, the sample is still relatively small. It is challen-
ging to acquire a sufficient amount of data from women
with CAIS given the low incidence rate of the syndrome,
estimated to be between 1:40,800 and 1:99,000 for all
subtypes (mild, partial, and complete) of AIS combined
[47]. Therefore, this methodological limitation, which
also applies to the digit ratio data, is difficult to
overcome.
Digit ratios
The previously reported sex difference in the 2D:4D ra-
tio, with larger digit ratios in women than men [18], was
replicated in the control groups, with moderate effect
sizes, in line with previous studies [48]. In addition, our
results in women with CAIS relative to the control
groups were similar to the findings presented by
Berenbaum et al. in 2009 [28]. The female-typical digit
ratios in women with CAIS, which are in line with
androgen-related effects on digit ratios, were replicated
in the right hand. In the present study, this result
reached significance while applying a more stringent
statistical threshold (two-tailed tests and correction for
multiple comparisons) than what was used in the previ-
ous study, thereby reducing the risk of a type I error.
The small-to-medium effect size for the difference be-
tween control men and women with CAIS was only
slightly smaller than in the study by Berenbaum et al.,
which was 0.61 for the right hand. In the present study,
this female-typical effect was not observed for the left
hand, which seems to be explained by a lower left-hand
2D:4D ratio in women with CAIS than in the study by
Berenbaum et al. However, after careful inspection of
the individual digit ratios from this previous study (Fig. 1,
[28]), there was one woman with CAIS who had a rather
extreme high left-hand digit ratio, which can explain the
higher mean left-hand digit ratio of women with CAIS
in that study. It is likely that a median for that same data
set, which is insensitive to extreme values, would be
lower and more similar to the median in our study.
It has been suggested that the sex difference in digit
ratio is generally larger in the right hand [18]. The
current results suggest a slightly larger effect size for the
sex difference in the right relative to the left hand. It has
been proposed that this could be the result of a greater
sensitivity of the right-hand digit ratio to prenatal testos-
terone [17], which might explain why women with CAIS
showed no significant deviations from either of the
control groups in the left hand. However, this lack of sig-
nificant differences prevents us from drawing firm con-
clusions regarding the left-hand digit ratios in women
with CAIS.
The analysis of the variability in digit ratios provides
additional information regarding the magnitude of the
potential influence of fetal androgen action on digit ra-
tios from both hands. Women with CAIS did not show
a reduced variability in digit ratios, which would be ex-
pected if androgen action alone determined digit dimen-
sions. This is also a replication of the findings from the
previous digit ratio study in women with CAIS [28], and
again indicates that variations in digit ratios reflect not
only variations in prenatal androgen action but also are
under the influence of additional factors. In line with
these findings, a meta-analysis of digit ratio studies
showed that the magnitude of the digit ratio sex differ-
ence is smaller than the magnitude of the sex difference
in amniotic testosterone levels [18]. Furthermore, classi-
fication of individual men and women according to their
digit ratios was not very reliable [28]. Finally, it should
be noted that amniotic testosterone levels might not tell
us much about localized androgen levels in the fetus
(i.e., in digits vs brain) at specific time points in
development.
Conclusions
The present observation that mean right ear CEOAE
amplitudes as well as mean right hand 2D:4D digit ratios
in CAIS women resembled values obtained in control
women as opposed to control men point to a possible
contribution of fetal androgen action to male-typical de-
velopment of these two variables. Even so, our finding
that the variability in both measures was similar across
all three groups argues against the notion that differ-
ences in CEOAE amplitudes and digit ratios solely re-
flect differences in fetal androgen exposure, or in
androgen exposure later in life. It might not be surpris-
ing that two previous studies measuring both digit ratios
and CEOAEs or SOAEs in the same subjects did not find
an association between these two biomarkers [48, 49]. Al-
though both authors have provided several possible expla-
nations for their finding, such as different developmental
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time windows for digit vs cochlear development, the ex-
planation stating that “neither measure exhibits a strong
relationship with the underlying prenatal processes” (as
cited in [49]) is most in line with current knowledge from
both the present and previous studies.
Taken together, the present results, along with results
from previous studies, suggest that fetal androgen expos-
ure is one factor contributing to the development of
male-typical digit ratios and CEOAE amplitudes. Our
present results together with those of Berenbaum et al.
[28] strongly suggest that additional non-androgenic fac-
tors are also needed to establish the male-typical pheno-
types for these variables. Consequently, neither marker
can be presumed to provide a reliable indication of pre-
natal androgen action and using these measures for this
purpose is not recommended. Further research is needed
to clarify what other factors in addition to fetal androgen
action determine male-typical digit ratios and CEOAEs
and what their exact timing and mechanisms of action
might be.
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